These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19724010)

  • 1. Fragile X syndrome: from molecular genetics to therapy.
    D'Hulst C; Kooy RF
    J Med Genet; 2009 Sep; 46(9):577-84. PubMed ID: 19724010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fragile X syndrome: exploring its molecular basis and seeking a treatment.
    Bardoni B; Davidovic L; Bensaid M; Khandjian EW
    Expert Rev Mol Med; 2006 Apr; 8(8):1-16. PubMed ID: 16626504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile X mental retardation syndrome: structure of the KH1-KH2 domains of fragile X mental retardation protein.
    Valverde R; Pozdnyakova I; Kajander T; Venkatraman J; Regan L
    Structure; 2007 Sep; 15(9):1090-8. PubMed ID: 17850748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental therapeutic models for fragile X syndrome].
    de Diego-Otero Y
    Rev Neurol; 2001 Oct; 33 Suppl 1():S70-6. PubMed ID: 12447824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in understanding fragile X syndrome and related disorders.
    Rooms L; Kooy RF
    Curr Opin Pediatr; 2011 Dec; 23(6):601-6. PubMed ID: 22001764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets.
    Kaufmann WE; Cohen S; Sun HT; Ho G
    Microsc Res Tech; 2002 May; 57(3):135-44. PubMed ID: 12112448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP.
    Linder B; Plöttner O; Kroiss M; Hartmann E; Laggerbauer B; Meister G; Keidel E; Fischer U
    Hum Mol Genet; 2008 Oct; 17(20):3236-46. PubMed ID: 18664458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome.
    Koukoui SD; Chaudhuri A
    Brain Res Rev; 2007 Jan; 53(1):27-38. PubMed ID: 16844227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
    Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
    J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fragile X syndrome: from molecular genetics to neurobiology.
    Willemsen R; Oostra BA; Bassell GJ; Dictenberg J
    Ment Retard Dev Disabil Res Rev; 2004; 10(1):60-7. PubMed ID: 14994290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome].
    Chiurazzi P; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of messenger RNAs and microRNAs associated with fragile X mental retardation protein.
    Duan R; Jin P
    Methods Mol Biol; 2006; 342():267-76. PubMed ID: 16957381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into Fragile X syndrome. Relating genotype to phenotype at the molecular level.
    Pozdnyakova I; Regan L
    FEBS J; 2005 Feb; 272(3):872-8. PubMed ID: 15670167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking the Fragile X mental retardation protein to the lipoxygenase pathway.
    Beaulieu MA
    Med Hypotheses; 2013 Mar; 80(3):289-91. PubMed ID: 23313071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exceptional good cognitive and phenotypic profile in a male carrying a mosaic mutation in the FMR1 gene.
    Govaerts LC; Smit AE; Saris JJ; VanderWerf F; Willemsen R; Bakker CE; De Zeeuw CI; Oostra BA
    Clin Genet; 2007 Aug; 72(2):138-44. PubMed ID: 17661818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fragile X continuum: new advances and perspectives.
    Cornish K; Turk J; Hagerman R
    J Intellect Disabil Res; 2008 Jun; 52(Pt 6):469-82. PubMed ID: 18444988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons.
    Davidovic L; Bechara E; Gravel M; Jaglin XH; Tremblay S; Sik A; Bardoni B; Khandjian EW
    Hum Mol Genet; 2006 May; 15(9):1525-38. PubMed ID: 16571602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS).
    D'Hulst C; Heulens I; Brouwer JR; Willemsen R; De Geest N; Reeve SP; De Deyn PP; Hassan BA; Kooy RF
    Brain Res; 2009 Feb; 1253():176-83. PubMed ID: 19070606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X syndrome: From protein function to therapy.
    Bagni C; Oostra BA
    Am J Med Genet A; 2013 Nov; 161A(11):2809-21. PubMed ID: 24115651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.